Avance Clinical Featured in Fierce Biotech on Intranasal Expertise - Avance Clinical

With the global intranasal drug delivery market estimated to reach up to $71 billion over the next five years, Avance Clinical is seeing an increase in biotech clinical trials targeting this growing…

Verily on LinkedIn: #hispanicheritagemonth

AIM-HI Accelerator Fund

Category: Company News - Page 3 - Avance Clinical

Category: Company News - Page 3 - Avance Clinical

Biomedicines, Free Full-Text

Clients and Others Combat COVID-19 (UPDATED 7/21/20) — Sales-Link, Inc.

Meet Neffy, the friendly epinephrine nasal spray from ARS Pharma awaiting FDA approval

Ramona Burress on LinkedIn: As the impact of COVID-19 grew in the US, so did our understanding of…

Category: Company News - Page 3 - Avance Clinical

SEC Filing

Life Science - Clinical Research Informer

Regulatory tracker: Merck's Keytruda picks up 2 new approvals in Europe

Fierce Medtech's 2020 Fierce 15